News

FOX 10 Phoenix12m

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

TD Cowen Lowers PT on Novo Nordisk (NVO), Keeps a Buy

Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued International Stocks According to Analysts. On August 19, TD Cowen ...